Press Releases

Press Release: Monday April 23, 2001
TheraLife^® Inc.'s Dr. Lily Yang to Present at "Golden State Venture Capital Conference & Entrepreneur Expo North Bay 2001"

TheraLife^® Inc. today announced that Dr. Lily Yang, CEO and President of TheraLife^® Inc. has been selected to present at the "Golden State Venture Capital Conference and Entrepreneur Expo North Bay, 2001" as one of the Gold Mine Presentation companies on April 23rd at the Embassy Suites, San Rafael, California.

TheraLife^® is a botanical drug company with a drug enhancement technology platform, which combines the benefits of faster delivery and reduced side effect. Because this technology can be used with a wide variety of ethical drugs and therapeutic agents, the market potential is enormous. TheraLife has already developed 5 tissue specific formulas, with market potential of $50 billion for treating medical conditions of the eye; wrist; neck and shoulder; back; and mental fatigue. TheraLife^® is in the process of extending this technology platform to cancer, cardiovascular, metabolic, autoimmune, and infectious diseases.

Dr. Yang will summarize results from a Stage I clinical trial study using TheraLife^® Eye plus Enhancer for the treatment of dry eyes, allergy and eye fatigue. Eye normally has poor circulation and difficult for oral medication to reach. This result further verifies the merits of the TheraLife^® Enhancer.

TheraLife^®'s corporate strategy is directed at forming joint ventures, marketing and distribution, product development, and licensing partnerships with major industry players. As such, TheraLife^® is focused on building a strong basis for attracting corporate partnerships through strong professional advocacy, clinical data and publications, quality manufacturing/ process control, and effective marketing communications.

Notice: This release and oral statements made from time to time by TheraLife^® representatives concerning the same subject matter may contain so-called "forward-looking statements." These statements can be identified by introductory words such as "expects", "plans", "will", "estimates", "forecasts", "projects", or words of similar meaning, and by the fact that they do not relate strictly to historical or current facts. Forward-looking statements frequently are used in discussing regulatory submissions and approvals, development programs, etc. Many factors may cause actual results to differ from forward-looking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known and other of which are not. No forward-looking statement is a guarantee of future results or events, and one should avoid paying undue reliance on such statements.

COMPANY CONTACT:
James Alston
E-mail: Jalston@theralife.com
(650) 917-1989
(650) 917-1434 fax
101 First Street
Los Altos, CA 94022